6533b873fe1ef96bd12d54f4
RESEARCH PRODUCT
Preliminary results from a phase I study of GBR 1302, a bispecific antibody T-cell engager, in HER2 positive cancers
Yacine SalhiM. BarveJ. BackSebastian OchsenreitherJohn S. KauhV. ReddyMartin WermkeJürgen Altsubject
0301 basic medicineBispecific antibodybusiness.industryT cellCancerPhases of clinical researchHematologymedicine.diseasePhase i study03 medical and health sciences030104 developmental biology0302 clinical medicinemedicine.anatomical_structureOncology030220 oncology & carcinogenesismedicineCancer researchbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | Annals of Oncology |